Pfizer and BioNTech have stopped their large U.S. COVID-19 vaccine trial in adults aged 50 to 64, citing insufficient ...
Pfizer and BioNTech have suspended their COVID-19 vaccine trial in adults aged 50 to 64 in the U.S. due to insufficient participant enrollment. The FDA's stringent requirements for placebo-controlled ...
Pfizer Inc PFE and its German COVID-19 vaccine partner BioNTech SE BNTX have reportedly halted recruitment for a large U.S.
By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...
Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) is FDA-authorized under Emergency Use Authorization (EUA) for use in individuals 12 years of age and older as a single ...
Add Yahoo as a preferred source to see more of our stories on Google. A vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at a mass vaccination center on July 1, 2021 in Leipzig, Germany.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results